It is also associated with prognosis in other carcinoma, such as pancreatic,esophageal squamous cancer, lung cancer and breast cancer by targeting MUC4, ZEB1, SRCIN1 and P2X7[24–27]. This evidence concerns the gene SRCIN1 and breast carcinoma.